Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chryseobacterium scophthalmum strain:1433

ABSTRACT: Chryseobacterium scophthalmum strain:1433 Genome sequencing and assembly

PROVIDER: PRJNA706143 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chryseobacterium scophthalmum

Project description:Chryseobacterium scophthalmum overview

| PRJNA416671 | ENA

Chryseobacterium scophthalmum strain:LGBM4

Project description:Chryseobacterium scophthalmum strain:LGBM4 Genome sequencing

| PRJNA1203911 | ENA

Chryseobacterium scophthalmum strain:VV8

Project description:Chryseobacterium scophthalmum Genome sequencing and assembly

| PRJNA416433 | ENA

Chryseobacterium scophthalmum strain:DSM 16779 | isolate:DSM 16779

Project description:Chryseobacterium scophthalmum DSM 16779 genome sequencing

| PRJNA329759 | ENA

A Novel β-Glucosidase From <i>Chryseobacterium scophthalmum</i> 1433 for Efficient Rubusoside Production From Stevioside.

Project description:As a natural sweetening and solubilizing agent, rubusoside has great potential in the application of healthy beverages and pharmaceuticals. However, the direct extraction and purification of rubusoside from raw materials is inefficient. In this work, a novel β-glucosidase (CsBGL) was obtained from Chryseobacterium scophthalmum 1433 through screening of the environmental microorganisms. CsBGL markedly hydrolyzed sophorese (Glcβ1-2Glc) and laminaribiose (Glcβ1-3Glc), but for steviol glycosides, it only hydrolyzed the C-13/C-19-linked sophorese, instead of the C-13/C-19-linked Glcβ1-2[Glcβ1-3]Glc trisaccharide and Glcβ1-monosaccharide. It efficiently hydrolyzed stevioside (240 g/L) to produce rubusoside (99% yield) at 47.5°C for 70 min. Even when using a crude steviol glycosides extract (500 g/L) containing ∼226 g/L stevioside as the substrate, CsBGL could also convert stevioside to rubusoside (99% yield) at 47.5°C for 2 h, in which the rubusoside concentration increased from the initial 42 g/L to the final 222 g/L. These results reveal that CsBGL would be a promising biocatalyst for the industry-scale production of rubusoside from stevioside or/and the crude steviol glycosides extract.

| S-EPMC8546341 | biostudies-literature

Analysis of differential gene expression in the degradation of doxycycline by Chryseobacterium sp. WX1

Project description:We isolated an efficient doxycycline degrading strain Chryseobacterium sp. WX1. To investigate gene expression patterns during doxycyclinedegradation by strain WX1, we conducted a comparative transcriptomic analysis using cultures of strain WX1 with and without doxycycline addition. The RNA-Seq data revealed that 90.44-96.56% of the reads mapped to the genome of Chryseobacterium sp. WX1 across all samples. Differentially expressed genes (DEGs) analysis (|log2FC| >2; p < 0.01) showed that 693 genes were significantly up-regulated and 592 genes were significantly down-regulated.

2023-09-12 | GSE242785 | GEO

Glaesserella parasuis strain:1433

Project description:Glaesserella parasuis strain:1433 Genome sequencing

| PRJNA872202 | ENA

Corynebacterium mastitidis strain:16-1433

Project description:Corynebacterium mastitidis strain:16-1433 Genome sequencing and assembly

| PRJNA421318 | ENA

Proteomic data on the biodegradation of doxycycline by Chryseobacterium sp. WX1

Project description:In this study, we isolated a potent doxycycline-degrading bacterium, Chryseobacterium sp. WX1, from environmental samples. To elucidate the molecular mechanisms underlying doxycycline degradation by strain WX1, we assessed and interpreted the proteomic profiles of Chryseobacterium sp. WX1 under conditions both with and without doxycycline exposure.

2023-09-07 | PXD045182 | Pride

Xanthomonas citri pv. fuscans strain:NCPPB 1433

Project description:Xanthomonas citri pv. fuscans strain:NCPPB 1433 Genome sequencing and assembly

| PRJNA264773 | ENA